Dynavax Technologies Corporati... ( DVAX )

Rate Stock
Overperform
Underperform
Sentiment:
100.00 /100
Last Price:
2.505
Change:
-0.20%
Key Indicators
Prev. Close 2.51
Day Range 2.44 - 2.52
52wk Range 1.74 - 5.10
Volume 1,584,739
Avg Vol. 5,070,019
Shares Outs. 182,891,013
Market Cap 458,141,988
P/E N/A
EPS -0.41
Dividend/Yield None / 0.00%
Stock Wall - DVAXLatest News - DVAX
DYNAVAX TECHNOLOGIES CORP Financials
Due Diligence in Finding the Value of Pharmaceuticals: Expert Portfolio Manager Finny Kuruvilla Discusses His Portfolio Construction Strategy with The Wall Street Transcript
See What These $15 Billion Managers Have Been Buying
3 Investment Strategy Lessons From Vertex's Success
DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
Wider-than-Expected Loss at Dynavax
Dynavax Reports First Quarter 2013 Financial Results
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Prin
Products with Higher Barriers to Generic Competition Yield Sustained Cash Flows: Expert Analyst David Amsellem Discusses the Brand Specialty Pharma Space with The Wall Street Transcript
Dynavax Picks New CEO
Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors
Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and E
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
Dynavax: A Compelling Buy
Solving The R&D Investment Dilemma With Project Funding: Mark Kessel
Biorunups: What To Expect In The Next Few Months
Dynavax Surprises: Announces Strategic Global Operations Hire
Dynavax Appoints David Novack as Senior Vice President, Operations and Quality
1 new update